Browse studies

Find your next paid study

27,375 recruiting studies available now

Using a Novel Mobile Cognitive Training Application to Improve Cancer-related Cognitive Impairment in Gynecologic Oncology Patients

Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients underg…

Gynecologic CancerChemotherapy EffectChemo-brain+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Alabama at BirminghamNCT05864274

Phase 1

Deformable Tissue Modelling and Augmented Reality Based Guidance for Head and Neck Tumor Re-Resection Task

Head and neck cancers have one of the highest recurrence rates among solid malignancies, and recurrence is strongly correlated with overall survival. Reducing …

PhysicianSurgeonResident Doctor+3 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT07686211

Observational

CORD-CHD: Clamp OR Delay Among Neonates With Congenital Heart Disease

The goal of this clinical trial is to compare 2 different timepoints for clamping the umbilical cord at birth for term-born infants with a prenatal diagnosis o…

Congenital Heart Disease (CHD)

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Carl Backes, MDNCT06153459

Phase 3

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher chance of getting wo…

Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT06966700

Phase 4

Evaluation of Energy Drinks on Electrocardiographic Parameters: A Randomized, Double Blind, Controlled, Crossover, Proof-of-concept Study

This is a clinical trial looking at the impact of energy drinks on heart related parameters. The study will enroll 3 participants who will be exposed to 8 diff…

Healthy VolunteersSafety After Oral Intake

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of the PacificNCT07212803

Longitudinal Study of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Post-Acute Sequelae of COVID-19 (PASC)

This study will examine how common Long COVID is and how symptoms may persist over time in people who have previously had COVID-19. Researchers will collect in…

SARS CoV-2 Post-Acute Sequelae

Estimated

~$10 – $750

Actual pay is set by the research site.

University of North Carolina, Chapel HillNCT07781501

Phase 1

Adaptive Radiation for Abdominopelvic Metastases (ARAM)

Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases. Adaptive SBRT will allow for escalation of the prescript…

Neoplasm - Soft Tissue Pelvis Malignant SecondaryMalignant Neoplasm of Stomach

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Fox Chase Cancer CenterNCT05880667

Phase 2

A New Intervention to Improve Function in Veterans With Anxiety and Depression

Anxiety and depression symptoms occur at high rates in Veteran populations and can significantly impact function, compromising the ability to work and to succe…

Anxiety and Depression

Estimated

~$75 – $1,800

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06188923

Phase 1

Phase 1/2A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

The main goals of this clinical trial are to find out what the best dose of the study drug, OTP-01, is for patients with solid tumors through understanding how…

Advanced Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ottimo Pharma LimitedNCT07266428

Observational

Musical Rhythm Sensitivity to Scaffold Social Engagement in Autism Spectrum Disorder

The primary goal of this study is to examine rhythm sensitivity as a predictor of response to naturalistic developmental behavioral intervention (NDBIs) in aut…

AutismAutism Spectrum Disorder

Estimated

~$10 – $750

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT05880225

Phase 2

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

To learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness o…

Dyspnea

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06336642

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of VERVE-102, a One-Time Dose Gene Editing Medicine, in Adults With or at High Risk for Atherosclerotic Cardiovascular Disease (ASCVD) Who Require Additional Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering

The purpose of this study is to measure the change in bad cholesterol (LDL-C) with VERVE-102 compared to placebo in adults who have plaque buildup in their art…

AtherosclerosisCardiovascular DiseaseHypercholesterolemia

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Verve Therapeutics, Inc.NCT07839936